Referee #1 (Remarks to the Author):
Tamura et al.: Mdm35p imports Ups proteins
Ups proteins are small soluble components of the intermembrane space (IMS) of mitochondria that play a critical role for mitochondrial lipid homeostasis. In this study, Tamura et al present evidence that the three Ups proteins of yeast form stable complexes with the protein Mdm35. The presence of Mdm35 in the IMS improves their translocation across the outer membrane and is critical for their stable accumulation in mitochondria. Based on these data, the authors suggest that Mdm35 plays a role as an import component for Ups proteins. The data presented are of high technical quality and well controlled. The study is very interesting and can certainly improve our understanding of the processes underlying mitochondrial lipid homeostasis. However, the presented data suggest that the primary function of Mdm35 is not the import of Ups proteins as stated in the title. Mdm35 rather forms a stable complex with Ups proteins in the IMS which is required for their accumulation in the IMS in a functional form. Therefore the title and parts of the discussion will need to be changed. Moreover, a number of points have to be addressed by the authors:
1. The central observation of the study is a permanent association of Ups proteins with Mdm35. Fig.  1 and earlier publications by the authors suggests that the three Ups proteins form distinct complexes of about 30 to 150 kDa. The study would be more convincing if the composition of the complexes would have been analyzed. Are Mdm35 and Ups proteins the only components of the complexes or do they contain further factors? Are complexes of the same size formed by incubation of recombinant Mdm35 with radiolabeled Ups proteins? 2. The import of Ups proteins is only slightly reduced in the absence of Mdm35. Thus, Mdm35 improves their import but is not an important factor for translocation. However, the steady state amounts of Ups proteins are severely reduced in Mdm35-deficient mitochondria. Thus, the main role of Mdm35 is not the import of Ups proteins but their stabilization in a functional form in the IMS. Thus, the title and parts of the Discussion should be rephrased. 3. The import of CCHL into the IMS of mitochondria depends on its binding to high affinity sites in the mitochondria. This study (Diekert and Lill, PNAS 96, 11752-11757) should be mentioned. The proposed model of protein import into the IMS driven by binding to complex partners is therefore not novel. 4. According to the proposed model the import of Ups proteins will depend on free pools of unbound Mdm35. Do these pools exist? What are the physiological concentrations of Ups1, Ups2, Ups3 and Mdm35. According to the model, the concentrations of Mdm35 need exceed the concentrations of Ups proteins considerably. 5. Are the amounts of Mdm35 limiting for import of Ups proteins? The authors should assess the import rates of Ups1, Ups2 and Ups3 into mitochondria of strains that overexpress Mdm35. 6. The crosslinking experiment shown in Fig. 5 indicate that at least small amounts of Ups proteins are in contact to Mdm35. To assess complex formation more quantitatively the authors should perform glycerol gradient experiments as shown in Fig. 1 with radiolabeled Ups proteins imported into wild type and Mdm35-deficient mitochondria. 7. The genetic screen of Osman et al identified not only Mdm35 but also the structurally related protein Emi1. The authors should test whether Emi1, like Mdm35, can interact with imported Ups proteins eg by comparison of crosslink patterns in Emi1-deficient mitochondria. An overlapping function of Mdm35 and Emi1 could explain why residual amounts of Ups proteins are found in Mdm35-deficient strains. 8. The crosslink experiment shown in Fig. 5B shows a prominent Mdm35-dependent crosslink product of about 55 kDa. This product supports the hypothesis that Mdm35 plays a role in Ups biogenesis and should be mentioned. 9. In the absence of Mdm35, but not in its presence, Ups2 migrates as a double band (Fig. 3B) . Is there any indication for a post-translational modification of Ups2?
Referee #2 (Remarks to the Author):
In this manuscript, Tamura and colleagues address the import of Ups proteins into the mitochondrial intermembrane space in yeast. They report that all 3 Ups proteins interact with the protein mdm35 and this complex is functional in the regulation of phospholipid metabolism. The authors find that Mdm35p not only regulates Ups function, but also acts to facilitate the import of Ups proteins into mitochondria. The work contributes new information on a poorly understood mechanism of protein import into this subcompartment and provides another route besides precursor protein trapping that is afforded by the Mia40 disulfide relay trap pathway and the protein folding/cofactor attachment pathway seen for the import of cytochrome c. The general significance of the work is quite high and will be of particular interest to researchers involved in the protein trafficking field. Some of the experimental procedures are novel and well performed (the antibody-shift experiments of protein complexes from sucrose gradients is a particularly nice technique), although other experiments require some additional controls and/or the use of statistical quantitation to strengthen their conclusions. The final interpretation of the work could also be clarified (see below).
1. Figure 1A: The authors indicate (pg 5) that the sizes of all cross-linked products increased in Mdm35pFLAG-expressing mitochondria but they need to clarify whether this corresponds to the addition of the flag-tag. Molecular weight marker positions should also be included to this panel. 2. Figure 1D : the authors show quite convincingly that Ups proteins interact with Mdm35p. The reliance on Mdm35p using recombinant proteins caps this off but the authors need to show that the interaction is specific by using a negative control protein as well. 3. Figure 3A: In the mdm35 delta mitochondria, the authors only show that the levels of outer membrane and inner membrane proteins are not changed. They need to also show that other IMS proteins are similarly unaffected (e.g. cytochrome c and a small Tim protein) to confirm that loss of Mdm35 specifically affects the levels of Ups proteins. Following this characterisation, the authors used a glucose-repressible system to deplete Mdm35 from yeast instead of using the mdm35delta strain. This use of this strain should be justified. 4. Figure 4B , 5A and 6: While the import effects appear strong, the authors need to show mean values from multiple import experiments (n=3) in the graphed results and include error bars. 5. Figure 7 shows that Ups2p overexpression can suppress the import defect seen in mdm35delta cells. This is a nice experiment and leads the authors to suggest that Mdm35 could either trap the Ups protein in the IMS or aid in Ups folding through some chaperone action. The authors could clarify this by isolating mitochondria from these Ups2p overexpressing cells and monitoring whether Ups2 can slip out of mitochondria over time (this would assess the potential trapping nature of Mdm35).
Referee #3 (Remarks to the Author):
This manuscript investigates the requirement for Ups1, Ups2, and Ups3 assembly and reports that a partner protein Mdm35 is also an import component. The Ups proteins have been identified as playing a role in phospholipid metabolism, but their specific function is not understood. The data are presented clearly and the results are interpreted carefully. The study is of general interest.
The authors consider the assembly notable because Mdm35 functions as an import component as well as a binding partner, but this may arguably not be that different than the import of other import components such as Tim22, Tim50, or Mia40 that require themselves for assembly. Can the authors also rule out that the Ups proteins are simply being imported into the intermembrane space and then being degraded by a protease because Mdm35 is not available for assembly? Do the authors know how these proteins function in phospholipid metabolism? It seems like Mdm35 is yet another component involved in lipid metabolism but a direct role in lipid metabolism has not been determined.
The following points should be specifically addressed:
1. In the import studies, rather than relying on a Gal-Mdm35, can the in vitro import experiments be performed with an mdm35 null strain? Referee #1
1. This referee and Referee #2 asked if Mdm35p is required for the accumulation of Ups proteins in the IMS. To address this question, we examined the release of Ups proteins from wildtype and mdm35∆ mitochondria. We found that the majority of Ups proteins are not released from both wildtype and mdm35∆ mitochondria after import (Fig. S2) . In the same experiment, we also showed that the stability of Ups proteins remains unaltered in the absence of Mdm35p. These new data indicate that Mdm35p is not required for the accumulation or stability of Ups proteins in mitochondria.
2. This referee asked whether Mdm35p and Ups proteins are the only components in Mdm35p-Ups complexes. To address this issue, the referee suggested that we examine the size of protein complexes formed by recombinant Mdm35p and radiolabeled Ups proteins using glycerol density gradient centrifugation. We have performed this suggested experiment. As presented in the revised manuscript (Fig. S1 ), Mdm35p and Ups proteins formed complexes in vitro and their sizes were similar to those observed in mitochondria. Our new data suggest that Mdm35p and Ups proteins are most likely the major components of Mdm35p-Ups complexes in mitochondria.
3. As suggested, we discussed the study by Diekert, et al. (PNAS 1999, 11752-11757) in the revised manuscript.
4. The referee requested that we determine the physiological concentrations of Mdm35p and Ups proteins. We agree that this is an important experiment, since our model suggests there is a pool of free Mdm35p. We performed the suggested experiment and found that Mdm35p is more abundant than Ups proteins (Fig. S3 ). These new data further support our model for Mdm35p-mediated import of Ups proteins.
5. As recommended, we added in vitro import analysis using Mdm35p-overexpressing mitochondria to the revised manuscript. Although Mdm35p was overexpressed approximately 4-fold, Ups protein import was similar in control and Mdm35p-overexpressing mitochondria (Fig. 4D) . Therefore, an increase in Mdm35p level does not enhance Ups protein import proportionally.
6. As suggested, we have tested whether Emi1p, a small protein carrying a twin cysteine motif that is structurally similar to Mdm35p, also mediates import of Ups proteins. We found that Emi1p does not associate with Ups proteins, and that the loss of Emi1p does not affect the amount of Ups proteins residing in mitochondria (Fig. S5) . These new results indicate that Emi1p is not involved in Ups protein import.
7. This referee noted that we should discuss an Ups2p-containing crosslinked product of approximately 55 kDa that disappears in the absence of Mdm35p (Fig. 5B ) since this finding further supports a role for Mdm35p in Ups protein biogenesis. We have included the suggested discussion in the revised manuscript.
8. This referee asked why Ups2p appears as a doublet in the absence of Mdm35p (Fig. 3B ). This is a very interesting point. We investigated whether this outcome stems from an alteration in phosphorylation or redox states (Fig. S4) . However, phosphatase treatment or substitution of cysteine residues did not affect the Ups2p doublet. These new data suggest that the appearance of the Ups2p doublet is independent of phosphorylation or redox state. We will address this issue further in future studies.
Referee #2
1. The referee suggested we confirm that the increase in size of crosslinked products in Mdm35p-FLAG mitochondria indeed results from the addition of the FLAG tag in Fig. 1A . To address this point, we performed immunoprecipitation studies using anti-FLAG antibodies in the revised manuscript (Fig. 1A right panel) . Further supporting our conclusion, the crosslinked products were immunoprecipitated by anti-FLAG antibodies in Mdm35p-FLAG mitochondria. We also indicate the calculated molecular weight in Fig. 1A .
Thank you for sending us your revised manuscript. Our original referee 1 has now seen it again. In general, he/she thinks that the referees' criticisms have been addressed adequately, but there is one exception. Referee 1 is not convinced that the experiment shown in supplementary figure S2 is sufficiently conclusive and that the issue whether Mdm35 is needed to stabilise newly imported Ups proteins still needs to be addressed experimentally. He/she puts forward a suggestion for a suitable experiment to sort out this point and I would like to ask you to follow this suggestion, before we can ultimately accept your manuscript.
Please let us have a suitably amended manuscript as soon as possible.
Yours sincerely,
Editor
The EMBO Journal
------------------------------------------------REFEREE COMMENTS

